Takeda Pharmaceutical Co (MEX:TAK N) Tariff Resilience Score : 8/10 (As of Jul. 15, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Tariff Resilience Score?

Takeda Pharmaceutical Co has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Takeda Pharmaceutical Co has Takeda has a diversified global supply chain and significant R&D operations in multiple countries, reducing tariff impact. Pharmaceuticals often have exemptions, and Takeda's strong market presence allows for pricing power.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Takeda Pharmaceutical Co might have Highly Resilient.

Competitive Comparison of Takeda Pharmaceutical Co's Tariff Resilience Score

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co's Tariff Resilience Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Tariff Resilience Score falls into.

Save Embed

;

Save Embed

;

Takeda Pharmaceutical Co (MEX:TAK N) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score	Resilience Level
7 - 10	Highly Resilient
4 - 6	Average Resilient
0 - 3	Highly Vulnerable

Takeda Pharmaceutical Co Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK N) » Definitions » Tariff Resilience Score

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA 4502:Japan 4502:Japan 4502:Japan 0A87:UK TKDA:Germany TKD:Germany TKD:Germany TKD:Germany TAKP34:Brazil TKD:Austria

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines